COMMUNIQUÉS West-GlobeNewswire
-
Inventiva Strengthens Leadership Team Ahead of Expected Phase 3 Data Readout of Lanifibranor
22/04/2026 -
Inventiva renforce son équipe de direction à l’approche des résultats de Phase 3 du lanifibranor
22/04/2026 -
OraSure to Announce First Quarter 2026 Financial Results and Host Earnings Call on May 6th
22/04/2026 -
EssilorLuxottica: Q1 2026 Revenue - Revenue rising 10.8% in Q1. Third consecutive quarter of double-digit growth
22/04/2026 -
Mind Lab Pro Unveiled: Does This “Universal Nootropic” Really Improve Focus, Memory & Brain Power? Read Mind Lab PRO Report!
22/04/2026 -
Romeo Orthopaedics Welcomes Lauren Hennessy, MPAS, PA‑C, to Their Esteemed Team
22/04/2026 -
MedShop Direct Expands White Glove Delivery and Installation of Adjustable Medical Beds for Assisted Living and Home Care Across 48 States
22/04/2026 -
Coloplast A/S - H1 2025/26 Earnings Release - Invitation for conference call on 12 May 2026 at 11:00 CEST
22/04/2026 -
Ipsen S.A. - Information relating to the holding of the Combined Shareholders’ Meeting of 13 May 2026
22/04/2026 -
Ipsen S.A. - Informations concernant la tenue de l’Assemblée Générale Mixte du 13 mai 2026
22/04/2026 -
EssilorLuxottica: Chiffre d'affaires T1 2026 - Chiffre d'affaires en hausse de +10,8 % au premier trimestre. Troisième trimestre consécutif de croissance à deux chiffres
22/04/2026 -
Providence Saint John’s Study Finds Lifestyle Program Improves Brain Health in Patients with Early Cognitive Impairment
22/04/2026 -
Philips receives FDA 510(k) clearance for its Rembra platform, expanding access to faster, more precise CT imaging across frontline care and cancer treatment planning
22/04/2026 -
PerfectServe Ranks #1 Across All Use Cases in the Gartner® Critical Capabilities for Clinical Communication and Collaboration Report
22/04/2026 -
LIfT BioSciences Announces Publication of Review Article in Frontiers in Immunology Highlighting Broad Therapeutic Potential of Neutrophils and IMANs in Cancer
22/04/2026 -
Adial Pharmaceuticals Successfully Completes Manufacturing of Demonstration Batch Production, Enabling Clinical and Registration Production for AD04 Planned Phase 3 Trial
22/04/2026 -
NETRIS Pharma: Nature publishes positive pancreatic cancer Phase 1b data for NP137 anti-netrin-1 monoclonal antibody
22/04/2026 -
EmblemHealth Expands Community Diabetes Wellness Program, Bringing Free, Citywide Support to New Yorkers
22/04/2026 -
Nexalin Technology Advances Pivotal Clinical Trial of HALO™ Clarity Toward Q2 2026 Enrollment
22/04/2026
Pages